Related Experiment Videos
Sequence and type-specific immunogenicity of the amino-terminal region of type 1 streptococcal M protein
W Kraus1, E Haanes-Fritz, P P Cleary
1Veterans Administration Medical Center, Memphis, TN 38104.
Abstract:
The NH2-terminal sequence of type 1 M protein was determined by automated Edman degradation of purified polypeptide fragments extracted from whole streptococci by limited digestion with pepsin. Three polypeptide fragments were purified by slab gel electrophoresis on sodium dodecyl sulfate (SDS) polyacrylamide followed by electroelution. The purified fragments migrated as 28-, 25-, and 23.5-kDa fragments, respectively. Each of the fragments inhibited opsonization of a diluted antiserum prepared in rabbits by immunization with whole type 1 streptococci. The amino-terminal sequences of the peptide fragments were confirmed by comparison with the primary structure predicted from the nucleotide sequence of the type 1 M protein structural gene. The 28-kDa fragment contained the NH2-terminal asparagine residue of the processed type 1 M protein, whereas the NH2-terminal sequences of the 25- and 23.5-kDa peptides began at residues 27 and 36, respectively. A seven-residue periodicity with respect to polar and nonpolar residues was observed beginning at residue 22 and, therefore, the secondary structural potential of type 1 M protein is similar to that reported for other M proteins. In contrast to the other M proteins, however, identical repeats were rare, the longest sequence identity consisting of a three-amino acid acid sequence Lys-Asp-Leu at positions 30-32 repeated once at positions 65-67. A 23-residue synthetic peptide of the amino-terminus of the type 1 M protein evoked opsonic antibodies against type 1 streptococci. These results indicate that the NH2-terminal region of type 1 M protein retains the secondary structural characteristics of other M serotypes. Moreover, it contains epitopes that evoke protective immune responses. Our studies may have bearing in the development of safe and effective vaccines against group A streptococcal infections.
Insights
The N-terminal region of type 1 M protein contains key epitopes for protective immunity against streptococci. This finding supports the development of novel vaccines for group A streptococcal infections.
Area of Science:
- Microbiology
- Immunology
- Protein Chemistry
Background:
- Streptococcus pyogenes (group A Streptococcus) is a significant human pathogen.
- M proteins are major virulence factors on the streptococcal surface, mediating resistance to phagocytosis.
- Understanding M protein structure and function is crucial for vaccine development.
Purpose of the Study:
- To determine the N-terminal sequence and structural characteristics of type 1 M protein.
- To identify regions of type 1 M protein that elicit protective immune responses.
- To assess the potential of type 1 M protein for vaccine development against group A Streptococcus.
Main Methods:
- Automated Edman degradation of pepsin-digested M protein fragments.
- Purification of polypeptide fragments using SDS-polyacrylamide gel electrophoresis and electroelution.
- Comparison of determined sequences with predicted structures from gene sequences.
- Synthesis of a 23-residue peptide for antibody induction studies.
Main Results:
- Three M protein fragments (28-, 25-, and 23.5-kDa) were purified and sequenced.
- The N-terminal region (residues 1-36) contains sequences critical for M protein structure and function.
- A synthetic N-terminal peptide induced opsonic antibodies against type 1 Streptococcus.
- The N-terminal region exhibits secondary structural periodicity similar to other M proteins, with limited repeats.
Conclusions:
- The N-terminal region of type 1 M protein possesses structural features common to other M serotypes.
- This region contains critical epitopes that induce protective, opsonic antibodies.
- These findings have implications for designing safe and effective vaccines against group A streptococcal infections.